Prevalence and associated factors of diabetic retinopathy in Rural Korea: The chungju metabolic disease cohort study

Journal of Korean Medical Science

Volumn 26, Issue 8, 2011, Pages 1068-1073

  Kim, Ji Hyun ^a   Kwon, Hyuk Sang ^a   Park, Yong Moon ^a   Lee, Jin Hee ^b   Kim, Man Soo ^a   Yoon, Kun Ho ^a   Lee, Won Chul ^a   Cha, Bong Yun ^a   Son, Ho Young ^a  

^a The Catholic University of Korea   (South Korea)

^b Catholic Institute of Ubiquitous Healthcare   (South Korea)

Author keywords

Diabetic retinopathy; Prevalence; Risk factors

Indexed keywords

GLYCOSYLATED HEMOGLOBIN; HEMOGLOBIN A1C PROTEIN, HUMAN;

AGED; ARTICLE; COHORT ANALYSIS; DIABETIC RETINOPATHY; ETHNOLOGY; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; MALE; MIDDLE AGED; NON INSULIN DEPENDENT DIABETES MELLITUS; PREVALENCE; RISK; RISK FACTOR; RURAL POPULATION; SOUTH KOREA;

AGED; BLOOD GLUCOSE; COHORT STUDIES; DIABETES MELLITUS, TYPE 2; DIABETIC RETINOPATHY; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; MALE; MIDDLE AGED; ODDS RATIO; PREVALENCE; REPUBLIC OF KOREA; RISK FACTORS; RURAL POPULATION;

EID: 80052689808     PISSN: 10118934     EISSN: 15986357     Source Type: Journal    
DOI: 10.3346/jkms.2011.26.8.1068     Document Type: Article

References (30)

1. King H, Aubert RE, Herman WH. Global burden of diabetes, 1995-2025: prevalence, numerical estimates, and projections. Diabetes Care 1998; 21: 1414-31.
2. Chan JC, Malik V, Jia W, Kadowaki T, Yajnik CS, Yoon KH, Hu FB. Diabetes in Asia: epidemiology, risk factors, and pathophysiology. JAMA 2009; 301: 2129-40.
3. Yoon KH, Lee JH, Kim JW, Cho JH, Choi YH, Ko SH, Zimmet P, Son HY. Epidemic obesity and type 2 diabetes in Asia. Lancet 2006; 368: 1681-8.
4. Porta M, Bandello F. Diabetic retinopathy: a clinical update. Diabetologia 2002; 45: 1617-34.
5. Klein R, Klein BE, Moss SE, Davis MD, DeMets DL. The Wisconsin Epidemiologic Study of Diabetic Retinopathy. III: prevalence and risk of diabetic retinopathy when age at diagnosis is 30 or more years. Arch Ophthalmol 1984; 102: 527-32.
6. Harris MI, Klein R, Welborn TA, Knuiman MW. Onset of NIDDM occurs at least 4-7 yr before clinical diagnosis. Diabetes Care 1992; 15: 815-9.
7. UK Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 1998; 352: 837-53.
8. Looker HC, Krakoff J, Knowler WC, Bennett PH, Klein R, Hanson RL. Longitudinal studies of incidence and progression of diabetic retinopathy assessed by retinal photography in pima indians. Diabetes Care 2003; 26: 320-6.
9. Leske MC, Wu SY, Hennis A, Nemesure B, Hyman L, Schachat A. Incidence of diabetic retinopathy in the Barbados Eye Studies. Ophthalmology 2003; 110: 941-7.
10. McCarty DJ, Fu CL, Harper CA, Taylor HR, McCarty CA. Five-year incidence of diabetic retinopathy in the Melbourne visual impairment project. Clin Experiment Ophthalmol 2003; 31: 397-402.
11. van Leiden HA, Dekker JM, Moll AC, Nijpels G, Heine RJ, Bouter LM, Stehouwer CD, Polak BC. Risk factors for incident retinopathy in a diabetic and nondiabetic population: the Hoorn study. Arch Ophthalmol 2003; 121: 245-51.
12. Kwon HS, Park YM, Lee HJ, Lee JH, Choi YH, Ko SH, Lee JM, Kim SR, Kang SY, Lee WC, Ahn MS, Noh JH, Kang JM, Kim DS, Yoon KH, Cha BY, Lee KW, Kang SK, Son HY. Prevalence and clinical characteristics of the metabolic syndrome in middle-aged Korean adults. Korean J Intern Med 2005; 20: 310-6.
13. World Medical Association. Declaration of Helsinki. Ethical Principles for Medical Research Involving Human Subjects. 52nd WMA General Assembly. Edinburgh: 2000.
14. World Health Organization. Definition, diagnosis and classification of diabetes mellitus and its complications part 1: diagnosis and classification of diabetes mellitus. World Health Organization, 1999.
15. Chalmers J, MacMahon S, Mancia G, Whitworth J, Beilin L, Hansson L, Neal B, Rodgers A, Ni Mhurchu C, Clark T. 1999 World Health Organization-International Society of Hypertension Guidelines for the management of hypertension. Guidelines sub-committee of the World Health Organization. Clin Exp Hypertens 1999; 21: 1009-60.
16. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972; 18: 499-502.
17. Wilkinson CP, Ferris FL 3rd, Klein RE, Lee PP, Agardh CD, Davis M, Dills D, Kampik A, Pararajasegaram R, Verdaguer JT; Global Diabetic Retinopathy Project Group. Proposed international clinical diabetic retinopathy and diabetic macular edema disease severity scales. Ophthalmology 2003; 110: 1677-82.
18. Lee HC, Yang JY, Lim SK, Hong CS, Huh KB, Lee SY. A prospective study of diabetic complications. J Korean Diabetes Assoc 1984; 8: 47-53.
19. Nam JH, Lee SH, Lee HJ, Han JH, Ha SW, Kim BW. The prevalence of chronic complications in non-insulin dependent diabetic patients. J Korean Diabetes Assoc 1999; 23: 702-14.
20. Park JY, Kim SW, Cho GY, Lee MH, Je SJ, Lee KU, Kim GS. The prevalence of micro- and macrovascular complications of Korean NIDDM patients. J Korean Diabetes Assoc 1993; 17: 377-85.
21. Lim S, Kim DJ, Jeong IK, Son HS, Chung CH, Koh G, Lee DH, Won KC, Park JH, Park TS, Ahn J, Kim J, Park KG, Ko SH, Ahn YB, Lee I. A nationwide survey about the current status of glycemic control and complications in diabetic patients in 2006: The Committee of the Korean Diabetes Association on the Epidemiology of Diabetes Mellitus. Korean Diabetes J 2009; 33: 48-57.
22. Chang C, Lu F, Yang YC, Wu JS, Wu TJ, Chen MS, Chuang LM, Tai TY. Epidemiologic study of type 2 diabetes in Taiwan. Diabetes Res Clin Pract 2000; 50(Suppl 2): S49-59.
23. Liu DP, Molyneaux L, Chua E, Wang YZ, Wu CR, Jing H, Hu LN, Liu YJ, Xu ZR, Yue DK. Retinopathy in a Chinese population with type 2 diabetes: factors affecting the presence of this complication at diagnosis of diabetes. Diabetes Res Clin Pract 2002; 56: 125-31.
24. Rema M, Premkumar S, Anitha B, Deepa R, Pradeepa R, Mohan V. Prevalence of diabetic retinopathy in urban India: the Chennai Urban Rural Epidemiology Study (CURES) eye study, I. Invest Ophthalmol Vis Sci 2005; 46: 2328-33.
25. Rani PK, Raman R, Chandrakantan A, Pal SS, Perumal GM, Sharma T. Risk factors for diabetic retinopathy in self-reported rural population with diabetes. J Postgrad Med 2009; 55: 92-6.
26. Cugati S, Kifley A, Mitchell P, Wang JJ. Temporal trends in the age-specific prevalence of diabetes and diabetic retinopathy in older persons: population-based survey findings. Diabetes Res Clin Pract 2006; 74: 301-8.
27. Tapp RJ, Shaw JE, Harper CA, de Courten MP, Balkau B, McCarty DJ, Taylor HR, Welborn TA, Zimmet PZ; AusDiab Study Group. The prevalence of and factors associated with diabetic retinopathy in the Australian population. Diabetes Care 2003; 26: 1731-7.
28. Hu YH, Pan XR, Liu PA, Li GW, Howard BV, Bennett PH. Coronary heart disease and diabetic retinopathy in newly diagnosed diabetes in Da Qing, China: the Da Qing IGT and Diabetes Study. Acta Diabetol 1991; 28: 169-73.
29. Wang WQ, Ip TP, Lam KS. Changing prevalence of retinopathy in newly diagnosed non-insulin dependent diabetes mellitus patients in Hong Kong. Diabetes Res Clin Pract 1998; 39: 185-91.
30. Agarwal S, Raman R, Kumari RP, Deshmukh H, Paul PG, Gnanamoorthy P, Kumaramanickavel G, Sharma T. Diabetic retinopathy in type II diabetics detected by targeted screening versus newly diagnosed in general practice. Ann Acad Med Singapore 2006; 35: 531-5.